Vimarsana
Biggest News Aggregation in the World

Skin Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Skin Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Skin Study Today - Breaking & Trending Today

German skin cancer patients join the EPIC-Skin study - Vimarsana News

German skin cancer patients join the EPIC-Skin study

/PRNewswire/ -- OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised...

Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study - Vimarsana News

Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study

/PRNewswire/ -- OncoBeta® GmbH today announced Perth's Hollywood Private Hospital in Australia is the latest medical facility to participate in the global...

Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT - Vimarsana News

Sydney skin cancer patients join the EPIC-Skin study as they undergo first treatments with OncoBeta's Rhenium-SCT

/PRNewswire/ -- OncoBeta® GmbH has announced its first Sydney-based patients were treated with Rhenium-SCT® as part of the global phase IV EPIC-Skin Study...

Austrian skin cancer patients take part in EPIC-Skin clinical study - Vimarsana News

Austrian skin cancer patients take part in EPIC-Skin clinical study

/PRNewswire/ -- OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised...

Austrian skin cancer patients take part in EPIC-Skin clinical study - Vimarsana News

Austrian skin cancer patients take part in EPIC-Skin clinical study

/PRNewswire/ -- OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised...